Effect of AAP statement regarding postnatal corticosteroids on ongoing and future randomized, controlled trials

Pediatrics. 2002 Nov;110(5):1032-3; author reply 1032-3. doi: 10.1542/peds.110.5.1032-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use*
  • Child, Preschool
  • Chronic Disease
  • Dexamethasone / adverse effects
  • Dexamethasone / therapeutic use*
  • Glucocorticoids / adverse effects
  • Glucocorticoids / therapeutic use
  • Humans
  • Infant
  • Infant, Newborn
  • Lung Diseases / drug therapy*
  • Lung Diseases / prevention & control
  • Organizational Policy
  • Pediatrics / standards*
  • Randomized Controlled Trials as Topic / standards*
  • Societies, Medical / standards
  • United States

Substances

  • Adrenal Cortex Hormones
  • Glucocorticoids
  • Dexamethasone